Location History:
- Boston, MA (US) (2004)
- Jamaica Plain, MA (US) (2008)
Company Filing History:
Years Active: 2004-2008
Title: Cecilia A Fernandez: Innovator in Antiangiogenic Peptides
Introduction
Cecilia A Fernandez is a notable inventor based in Jamaica Plain, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antiangiogenic peptides. With a total of 2 patents to her name, her work has the potential to impact medical treatments significantly.
Latest Patents
Her latest patents include innovative formulations of antiangiogenic polypeptides. The first patent describes an antiangiogenic polypeptide with a specific amino acid sequence that effectively inhibits endothelial cell proliferation. This invention demonstrates at least 50% inhibition of bFGF-stimulated endothelial cell proliferation at concentrations ranging from 5 µg/ml to 20 µg/ml, with optimal results showing up to 95% inhibition. The second patent further elaborates on this concept, providing a similar polypeptide that also achieves significant inhibition of endothelial cell proliferation, reinforcing the potential therapeutic applications of her work.
Career Highlights
Cecilia A Fernandez is associated with the Children's Medical Center Corporation, where she continues to advance her research in the field of antiangiogenic therapies. Her work is crucial in developing treatments that could help manage various medical conditions related to abnormal blood vessel growth.
Collaborations
Cecilia has collaborated with esteemed colleagues such as Marsha A Moses and Inmin Wu, contributing to a rich environment of innovation and research.
Conclusion
Cecilia A Fernandez stands out as a pioneering inventor in the realm of antiangiogenic peptides, with her patents reflecting a commitment to advancing medical science. Her contributions are poised to make a lasting impact on therapeutic strategies in the future.